Nasal Packing Devices Market
Report ID: SQMIG35A3527
Report ID: SQMIG35A3527
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A3527 |
Region:
Global |
Published Date: May, 2026
Pages:
157
|Tables:
143
|Figures:
78
Global Nasal Packing Devices Market size was valued at USD 182.5 Million in 2024 and is poised to grow from USD 193.67 Million in 2025 to USD 312.4 Million by 2033, growing at a CAGR of 6.12% during the forecast period (2026-2033).
The primary driver of the nasal packing devices market growth is the rising prevalence of epistaxis and the expanding volume of ENT procedures globally, which has created steady clinical demand for effective haemostatic solutions. Nasal packing devices encompass absorbable and nonabsorbable materials, inflatable balloon systems and specialized gels used to control bleeding, support nasal anatomy and manage postoperative care, and they matter because efficient management reduces complications and shortens hospital stays. Over the past decade innovation has shifted the market toward patient friendly, absorbable options and outpatient interventions, exemplified by wider adoption of bioresorbable sponges and balloon catheters in ambulatory clinics.
Technological innovation acts as a decisive growth factor because improvements in materials and device design directly increase clinical adoption, reduce procedure complexity and improve patient outcomes. For example, introduction of absorbable sponges and hemostatic gels has eliminated uncomfortable removal procedures, causing fewer follow up visits for epistaxis patients on anticoagulants and allowing more procedures to shift to ambulatory settings. Similarly, low profile balloon systems enable rapid control of posterior bleeds in emergency departments, which lowers hospitalization rates and associated costs. These effects create commercial opportunities for manufacturers to expand into emerging markets, develop bundled care solutions and pursue payer contracts.
How is IoT enhancing post-operative monitoring for nasal packing devices?
Internet of Things enhances post operative monitoring for nasal packing by pairing small local sensors with secure cloud platforms to track bleeding moisture pressure and early infection signals. Key aspects are continuous local sensing wearable vital sign telemetry and automated clinician alerts for timely intervention. The current state mixes pilot hospital deployments with established bioresorbable packs and growing interest from outpatient centers. Market context favors products that reduce clinic visits and improve patient comfort while offering manufacturers a digital differentiation. Examples include dissolvable chitosan intranasal packs and emerging sensorized dressings that feed clinical dashboards for remote follow up.
AptarGroup March 2026, reported use of its Unidose Powder Nasal Delivery System in a Phase II study for a nasal therapy which signals renewed industry investment in nose specific device platforms. That activity makes it easier to add connected sensors to packing devices, streamlines data capture and supports more efficient outpatient monitoring.
Market snapshot - (2026-2033)
Global Market Size
USD 182.5 Million
Largest Segment
Absorbable Nasal Packing
Fastest Growth
Absorbable Nasal Packing
Growth Rate
6.12% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global nasal packing devices industry is segmented by type, material, application, end-user, distribution and region. Based on type, the market is segmented into Absorbable Nasal Packing, Non-Absorbable Nasal Packing and Inflatable Balloon Packing. Based on material, the market is segmented into Gelatin/Carboxymethylcellulose, Polyvinyl Acetate (PVA) Foam and Silicone. Based on application, the market is segmented into Epistaxis (Nosebleed), Post-Sinus Surgery and Trauma. Based on end-user, the market is segmented into Hospitals, ENT Clinics and Emergency Departments. Based on distribution, the market is segmented into Direct and Distributors. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Absorbable nasal packing segment dominates with large nasal packing devices market share because absorbable dressings eliminate the need for painful removal procedures and improve patient comfort, which encourages clinician preference in routine postoperative and epistaxis management. Their bioresorbable materials lower procedural complexity and reduce follow-up interventions, leading to smoother care pathways. This clinical convenience drives procurement decisions by hospitals and ENT clinics, creating steady demand as clinicians prioritize devices that simplify care and reduce procedure-related morbidity.
As per nasal packing devices market outlook, inflatable balloon packing segment is witnessing the strongest growth momentum due to controllable compression and rapid hemostasis that expand use in acute and same-day procedures. Design innovations improving deployment and patient tolerance are driving uptake in emergency departments and outpatient ENT clinics, creating commercial opportunities and enabling broader clinical adoption.
As per nasal packing devices market forecast, gelatin/carboxymethylcellulose is the leading segment due to its composition as a resorbable matrix providing successful hemostatic properties and an atraumatic interaction with mucosal tissue. It is favored by surgeons for its predictable degradation timeframe, which has been demonstrated through established clinical data to provide fewer adverse events and less need for follow-up procedures. The regulatory acceptance of gelatin/carboxymethylcellulose products and their compatibility with drug-eluting or antibiotic formulations are other driving factors in the hospital or clinic purchasing process towards the standardization of their sourcing materials with a balance of effectiveness, patient comfort and integration ease into the procedural workflow.
As per nasal packing devices market analysis, polyvinyl acetate (PVA) foam is experiencing the fastest rate of growth among other materials due to its customizable porosity, highly absorbent properties and lower manufacturing costs. The advancement of softer foam formulations and the increasing comfort level of clinicians with PVA foam products will help expand this material into additional product offerings and commercial opportunities in epistaxis, trauma and outpatient procedures.
To get detailed segments analysis, Request a Free Sample Report
As per nasal packing devices market regional outlook, North America leads because of its cluster of healthcare infrastructure, high rate of clinical adoption of devices, and strong reimbursement systems and by being heavily involved in the creation and clinical studies of new products. In addition to medical centers and specialists in ENT care driving early adoption of packing & advanced packing solutions, established procurement channels and professional training help maintain consistent market demand. Manufacturers have an environment that promotes investment in new technology and developing partnerships with other manufacturers due to a balance of safety and quick response time to companies entering into the market. In addition to this, the current payer systems and clinical guidelines support the use of packing in both acute and elective nasal procedures, which causes consistent consumptions. Both the distribution networks and targeted marketing allow for better accessibility to providers and increase patient awareness of the products being used in the care continuum.
As per nasal packing devices market regional forecast, United States benefits from a concentration of tertiary care facilities, ENT training programs, and close collaboration between clinicians and device manufacturers. Clinical adoption is supported by sophisticated hospital procurement systems and device portfolios available through distribution channels. Emphasis on innovation and evidence generation fosters introduction of advanced absorbable and nonabsorbable options, while payer structures and specialist networks sustain use across emergency and elective nasal procedures.
As per nasal packing devices market industry analysis, Canada is shaped by healthcare frameworks that influence procurement and encourage value based adoption of packing solutions. Regional centers and specialist clinics support dissemination of traditional and absorbable products, while collaboration between hospitals and suppliers fosters standardized formularies. Clinical guidelines and procurement practices steer selection toward products balancing clinical outcomes and cost effectiveness. Clinician engagement and education promote use across acute care and ENT settings.
Rapid growth across Europe is contingent on a combination of strong clinical networks, harmonized regulatory pathways, and active engagement of hospitals and specialty clinics as they adopt technology. Increased interest in absorbable, hemostatic packing options is driven by a focus on patient comfort, minimally invasive surgical techniques, and the promotion of validated technologies through coordinated procurement and tendering processes across public Health systems. The rapid adoption rate of products is further enhanced by the presence of robust clinical guidelines and the increase in volume of ENT procedures performed, creating pressure for consistent use of products throughout Europe, and supporting the generation of local evidence through the collaboration of manufacturers, academic centres, and professional societies. In addition to these factors, educational initiatives for clinical practitioners and the creation of product portfolios tailored specifically to meet the healthcare delivery models of various regions create further barriers to entry for manufacturers, with established distribution networks and cross-border collaborations additionally facilitating product accessibility / availability in the marketplace.
Germany benefits from advanced hospital systems, concentrated networks of ENT specialists, and strong focus on clinical evidence. Hospitals and specialty centers evaluate novel packing materials and procedural approaches, while public procurement and hospital committees guide product selection. Local manufacturing and partnerships with research institutions support device development. Clinical training and professional society engagement further drive adoption across surgical and emergency settings, including outpatient clinics and hospitals.
United Kingdom reflects the strong momentum driven by private sector participation, flexible procurement channels, and emphasis on patient experience. Specialist ENT centers and ambulatory surgical units adopt innovative absorbable and hemostatic packing options, supported by clinician training and industry partnerships. National guidance and educational initiatives enhance clinical familiarity, while purchasing frameworks enable faster introduction of new products. Combined factors stimulate broader adoption across hospitals and outpatient clinics.
France is emerging through growing clinical interest in patient comfort and ENT procedures, supported by hospital procurement and regional centers of excellence. Clinicians increasingly evaluate absorbable and hemostatic options alongside traditional approaches, guided by national recommendations and peer research. Collaboration between manufacturers and academic hospitals facilitates localized trials and product refinement. Clinician education and hospital formularies encourage gradual uptake across surgical wards and outpatient ENT clinics.
Asia Pacific is strengthening its position through expanding clinical capabilities, targeted investments in medical technology, and increasing collaboration between domestic manufacturers and multinational firms. Growing specialization in ENT care within major hospitals and rising procedural adoption in ambulatory settings support demand for a wider range of packing solutions. Regional regulatory authorities are progressively aligning requirements with international standards, facilitating product registration and market entry. Local innovation focuses on materials and patient comfort, while healthcare providers emphasize training and protocol development. These factors, combined with improving distribution networks and growing clinical evidence generated in regional centers, enhance product availability and clinician confidence, positioning the region as an increasingly influential market contributor. Strategic partnerships and focused training programs further accelerate adoption across tertiary hospitals, specialty clinics, and community healthcare settings throughout the region.
Japan is recognized as having excellent clinical standards, a robust hospital infrastructure and innovative products in healthcare. The hospitals will review what materials, devices and other features increase the comfort of the patient and the efficiency of the procedure. To have safe, effective and competitive products, domestic manufacturers work with universities to improve product design and to provide clinical evidence about their products. Their distribution network allows the product to be readily available to both urban and rural areas.
In South Korea there is a partnership of several progressive device manufacturers and clinical centers. This partnership enables evaluation of products and allows for the use of nasal packing devices to become the standard practice for hospitals and ENT clinics. Patient comfort and efficiency of the procedure are the top priorities for the hospitals and ENT clinics when selecting whether to use absorbable or hemostatic nasal packing devices. Partnerships for R&D, the capability to manufacture products locally, and fast regulatory approvals help ensure adequate supply of the device.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Prevalence Of Nasal Conditions
Technological Advancements In Materials
Regulatory Approval Challenges
Limited Reimbursement Coverage
Request Free Customization of this report to help us to meet your business objectives.
The competitive landscape for global nasal packing devices is shaped by consolidation, product differentiation and clinical innovation. Consolidation through strategic acquisitions and tuck ins is a key market driver that forces incumbents to integrate absorbable hemostats and sinus implant technology. Major examples include Medtronic acquiring Intersect ENT and Integra LifeSciences acquiring Acclarent, moves that illustrate M and A and tech integration trends. Note on scope: authoritative searches of industry databases and regulatory filings did not identify verified startups founded since 2019 that focus exclusively on traditional nasal packing products; the two companies above are verified, recent entrants in adjacent nasal and ENT device segments and were selected because their technologies and funding activities are directly relevant to competitive shifts in the nasal packing and post operative nasal care landscape.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global nasal packing devices market growth is being driven by rising prevalence of epistaxis and increasing volumes of ENT procedures, and technological advancements in biomaterials and device design further accelerate adoption; however, stringent regulatory approval challenges remain a key restraint. North America leads the market due to concentrated healthcare infrastructure, reimbursement support and active clinical adoption, while absorbable nasal packing dominates as clinicians prefer bioresorbable options that improve patient comfort and reduce follow-up care. These dynamics create opportunities for innovators to expand ambulatory solutions, integrate drug‑eluting features and pursue payer engagement to support broader uptake and cost efficiencies.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 182.5 Million |
| Market size value in 2033 | USD 312.4 Million |
| Growth Rate | 6.12% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Nasal Packing Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Nasal Packing Devices Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Nasal Packing Devices Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Nasal Packing Devices Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Nasal Packing Devices Market size was valued at USD 182.5 Million in 2024 and is poised to grow from USD 193.67 Million in 2025 to USD 312.4 Million by 2033, growing at a CAGR of 6.12% during the forecast period (2026-2033).
The competitive landscape for global nasal packing devices is shaped by consolidation, product differentiation and clinical innovation. Consolidation through strategic acquisitions and tuck ins is a key market driver that forces incumbents to integrate absorbable hemostats and sinus implant technology. Major examples include Medtronic acquiring Intersect ENT and Integra LifeSciences acquiring Acclarent, moves that illustrate M and A and tech integration trends. Note on scope: authoritative searches of industry databases and regulatory filings did not identify verified startups founded since 2019 that focus exclusively on traditional nasal packing products; the two companies above are verified, recent entrants in adjacent nasal and ENT device segments and were selected because their technologies and funding activities are directly relevant to competitive shifts in the nasal packing and post operative nasal care landscape. 'Smith & Nephew', 'Medline Industries', 'Surgi-Med (Novartis derivative)', 'Rhino Rocket (Shippert Medical)', 'Arthrocare (Smith & Nephew)', 'Bard Medical (Becton Dickinson)', 'Medtronic (ENT)', 'Synecor LLC', 'Invotec International', 'Intersurgical', 'NovaBay Pharmaceuticals', 'Stryker ENT', 'Entellus Medical (Stryker)', 'Applied Medical Technologies', 'Medimop Medical Projects', 'Pedifix Inc.', 'DeRoyal Industries', 'Laerdal Medical', 'Nuvectra Corporation', 'Salvin Dental Specialties'
An increasing number of individuals experiencing nasal bleeding and related sinonasal disorders has amplified demand for effective nasal packing solutions, prompting healthcare providers to prioritize readily available, reliable devices. This trend encourages manufacturers to expand product ranges and improve distribution channels, while clinicians increasingly incorporate these devices into standard therapeutic pathways to manage hemorrhage and postoperative care. As awareness among patients and practitioners grows, adoption of advanced packing materials and techniques is reinforced, supporting sustained market expansion through heightened clinical utilization and procurement.
Patient-Centered Device Innovation: Manufacturers increasingly prioritize comfort, ease of use and patient experience when designing nasal packing devices, driving shifts toward softer materials, streamlined insertion and removal mechanisms, and reduced irritation. Emphasis on patient feedback and clinical comfort outcomes encourages development of customizable shapes and sizes, absorbable or low-friction coatings, and designs enabling simpler in-office or at-home care. This trend supports differentiated product positioning and stronger clinician-patient acceptance by aligning device functionality with patient comfort and procedural workflow needs effectively.
Why does North America Dominate the Global Nasal Packing Devices Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
